Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000920750 | SCV001066127 | likely benign | 3-methylcrotonyl-CoA carboxylase 2 deficiency | 2024-01-15 | criteria provided, single submitter | clinical testing | |
Ce |
RCV004569813 | SCV005051378 | likely benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | MCCC2: BP4, BP7 |
Breakthrough Genomics, |
RCV004569813 | SCV005225556 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV000920750 | SCV001452996 | uncertain significance | 3-methylcrotonyl-CoA carboxylase 2 deficiency | 2020-01-24 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003902992 | SCV004722700 | likely benign | MCCC2-related disorder | 2019-08-01 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |